Unlike hexarelin, tesamorelin induces a physiological GH release pattern
The drug is indicated for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related ailment or in patients with a BMI of 30 kg/m2 or greater
Patients with minimal excess weight sometimes experience meaningful pressure reductions through endothelial improvements and sympathetic nervous system rebalancing
Furthermore, a nationally endorsed framework for switching would reduce the variation between providers, prevent unsafe practices such as stockpiling or online sourcing, and shield the NHS from increased demand and resources both in the short-term and long-term
But the glucagon receptor is where retatrutide truly separates itself
Treatment protocols are individualized and monitored under provider supervision to ensure safety, tolerability, and appropriate clinical oversight